Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2023-08-12 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2023-08-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation about a conference call to discuss the un-audited financial results for the quarter ended June 30, 2023. It is a notification of an upcoming event rather than the actual financial results or their transcript. The document references a conference call for analysts and investors, scheduled for a future date, and provides dial-in details and registration information. It does not contain financial data, management discussion, or the transcript of the call itself. Therefore, it is best classified as a Call Transcript (CT) related announcement, but since it is only an intimation about the call and not the transcript, it does not fit CT. It is not a report or earnings release but an announcement about the call. Given the options, the closest and most appropriate classification is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories. The document length is short (2783 characters), and it is an announcement rather than a report or transcript. Hence, the classification is RNS with high confidence.
2023-08-07 English
Board Meeting — ADVANCED ENZYME TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the…
Regulatory Filings
2023-08-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing about an upcoming Board Meeting scheduled to approve unaudited financial results for the quarter ended June 30, 2023, and the closure of the trading window. It does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. The document is an announcement related to corporate governance and compliance with trading regulations. Given its nature and length (1466 characters), it fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Board/Management Information (MANG), since it is primarily an intimation to stock exchanges and shareholders about the meeting and trading window closure, not a management change or detailed report.
2023-08-04 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter responding to a stock exchange query about unusual trading volume. It clarifies that there is no undisclosed material information affecting the share price or volume. The document is a regulatory communication to the stock exchange, not a financial report, earnings release, or any other detailed filing. It does not contain financial data or report results but is a compliance-related disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance communications.
2023-07-31 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, related to the quarter ended June 30, 2023. It is a short letter addressed to stock exchanges, signed by the company secretary, and mentions an enclosed certificate from the registrar and transfer agents. The document length is only 1025 characters, indicating it is a brief certification or attestation rather than a full financial report. It does not contain financial statements or substantive financial data. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is primarily a regulatory compliance certificate and not a full report or announcement of a report publication.
2023-07-17 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.